We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Hasta La VISTA, Pancreatic Cancer!

News   Jan 14, 2019 | Original story from The University of Texas MD Anderson Cancer Center

 
VISTA Checkpoint a Potential Pancreatic Cancer Immunotherapy Target

Image credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Cobra Biologics Announce Major Expansion of Manufacturing Facilities in US and Europe

News

Cobra is undertaking a multi-phase augmentation of its plasmid DNA services as a continuation of its Advanced Therapy expansion project.

READ MORE

Synthesis of Potent Antibiotic Involves Unusual First Steps

News

Images of a protein involved in creating a potent antibiotic reveal key steps involved in the antibiotic’s synthesis. This understanding could enable researchers to adapt this and similar compounds for use in human medicine.

READ MORE

Computational Tool Differentiates Between Data From Cancer Cells and Normal Cells

News

Researchers have created a new computational technique to accurately differentiate between single-cell RNA-sequencing data from cancer cells and the variety of normal cells found within tumor samples.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE